Pharmaceutical Industry Strategy Group

In May 2008 the Minister for Innovation, Industry, Science and Research commissioned the Pharmaceuticals Industry Strategy Group (PISG) to develop a strategic plan to increase investment in pharmaceuticals research and development (R&D) and manufacturing in Australia over the next decade.

The Australian pharmaceuticals industry is defined as all those who contribute to the discovery, creation and supply of pharmaceutical products and services, including prescription medicines and vaccines. It covers research from discovery, through clinical trials, to manufacturing and includes the originator medicine sector, the generic medicine sector and the medical biotechnology sector.

The pharmaceuticals industry is highly globalised and is undergoing a period of rationalisation that will impact on the sustainability of the Australian industry. The Group was therefore tasked with looking at the drivers and barriers to increasing productive investment in R&D; identifying strategies to increase investment and build on Australia's competitive strengths; and actions that should be taken by industry and Government to increase investment and activity in discovery, production and manufacturing.
The Group was responsible for delivering a draft directions paper by 30 September 2008 with  a final report by the end of December 2008.

The September draft directions paper is available at
www.innovation.gov.au/Industry/Pharmaceuticals/Documents/PISG_Directions_Paper_final_I.pdf

Content Updated January 2009